Sage Therapeutics Inc (SAGE)
12.95
+0.06
(+0.47%)
USD |
NASDAQ |
Apr 23, 16:00
14.72
+1.77
(+13.67%)
Pre-Market: 08:04
Sage Therapeutics Gross Profit (Quarterly): 77.15M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 77.15M |
September 30, 2023 | 1.811M |
June 30, 2023 | 2.269M |
March 31, 2023 | 3.064M |
December 31, 2022 | 2.722M |
September 30, 2022 | 1.555M |
June 30, 2022 | 1.301M |
March 31, 2022 | 1.296M |
December 31, 2021 | 1.555M |
September 30, 2021 | 1.309M |
June 30, 2021 | 1.495M |
March 31, 2021 | 1.396M |
Date | Value |
---|---|
December 31, 2020 | 1.109B |
September 30, 2020 | 1.49M |
June 30, 2020 | 0.979M |
March 31, 2020 | 2.116M |
December 31, 2019 | 1.741M |
September 30, 2019 | 3.433M |
June 30, 2019 | 0.829M |
March 31, 2019 | 0.465M |
December 31, 2018 | 0.273M |
September 30, 2018 | 0.00 |
June 30, 2018 | 90.00M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.829M
Minimum
Jun 2019
1.109B
Maximum
Dec 2020
64.03M
Average
1.555M
Median
Dec 2021
Gross Profit (Quarterly) Benchmarks
Biogen Inc | 1.768B |
Perspective Therapeutics Inc | -- |
Vanda Pharmaceuticals Inc | 41.81M |
ADMA Biologics Inc | 31.09M |
Finch Therapeutics Group Inc | -- |